⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

April 1, 2024

[Clinical Analysis of Mitoxantrone Liposome in the Treatment of Children with High-Risk Acute Myeloid Leukemia].

Yuqing Jiao Hao Xiong Zhi Chen Li Yang Tao Fang Ming Sun Shanshan Qi Wenjie Lu Zhuo Wang Yu Du Linlin Luo

View Full Paper

Ask AI

Bookmark

Share

Abstract

To investigate the safety and efficacy of mitoxantrone liposome in the treatment of children with high-risk acute myeloid leukemia (AML).

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Jiao et al. (2024) studied this question.

synapsesocial.com/papers/68e70f02b6db643587688cbd https://doi.org/10.19746/j.cnki.issn.1009-2137.2024.02.006

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1The Applications of Mitoxantrone and Its Liposome in Adult Acute Myeloid Leukemiareview · 2023 · 1 citations
2Real-world effectiveness of mitoxantrone hydrochloride liposome containing regimens in acute myeloid leukemia2025 · 1 citations
3Population pharmacokinetics and dose–response relationships of mitoxantrone in children with acute myeloid leukaemiaClinical Trial · 2026
4Phase I clinical and pharmacokinetic evaluation of high-dose mitoxantrone in combination with cytarabine in patients with acute leukemia.cohort · 1993 · 60 citations
5Pharmacokinetics of Mitoxantrone in Plasma and Leukemic Cells During Treatment of Patients with Acute Non-Lymphocytic Leukemiacohort · 1992 · 9 citations